CHEMBL1176

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvalYear 1976
gptkbp:ATCCode gptkb:C07AB03
gptkbp:bioavailability 50% (oral)
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:contraindication asthma
severe bradycardia
cardiogenic shock
second- or third-degree heart block
gptkbp:drugClass beta blocker
beta-adrenergic antagonist
gptkbp:eliminationHalfLife 6-7 hours
gptkbp:excretion gptkb:kidney
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasLogP 0.16
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:hasSMILES CC(C)NCC(COC1=CC=CC=C1O)O
gptkbp:hasTherapeuticUse antianginal agent
antiarrhythmic agent
antihypertensive agent
gptkbp:hasUNII 50VV3VW0TI
https://www.w3.org/2000/01/rdf-schema#label CHEMBL1176
gptkbp:indication gptkb:arrhythmia
myocardial infarction
hypertension
angina pectoris
gptkbp:isApprovedDrug true
gptkbp:legalStatus prescription only
off-patent
gptkbp:listedOn gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:manufacturer gptkb:AstraZeneca
gptkbp:mechanismOfAction beta-1 adrenergic receptor antagonist
gptkbp:meltingPoint 152-155°C
gptkbp:metabolism liver
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:pregnancyCategory C (US)
gptkbp:proteinBinding 6-16%
gptkbp:PubChem_CID 2162
CHEBI:2269
DB00335
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect dizziness
fatigue
hypotension
bradycardia
cold extremities
gptkbp:synonym gptkb:Atenololum
gptkb:Tenormin
gptkbp:target beta-1 adrenergic receptor
gptkbp:bfsParent gptkb:fingolimod
gptkbp:bfsLayer 6